ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Adopting mHealth Technologies in CV Trials
A Pharmafile article authored by Marie McCarthy and Jack Martin on the use of mHealth technologies in cardiovascular trials.
Rare Disease Trials Q&A
A PME article discussing the challenges of rare disease trials, including those of recruitment and retention unique to rare disease studies.
The Need for New Business Models under MDR/IVDR
A thought leadership article on the approaching deadline for the new medical devices regulation (MDR) & in vitro diagnostic device regulation (IVDR).
ICER's Growing Impact On Drug Pricing And Reimbursement
Read Forbes' article featuring ICON research insights exploring how ICER may have a greater impact on payer decision-making than expected.
The Rise of Patient-Centricity
In the April 2019 issue of PME, ICON's Matt McCarty discusses the importance of understanding what patients value and ways to gather patient insights.
ICON CIO – Telemedicine, Wearables & AI Could Boost Clinical Trial Participation
A Diginomica article featuring commentary from Tom O’Leary, discussing the opportunities for technology to overcome key challenges in clinical trials.
Embracing Digital Health
An article by Vicki Anastasi, Matt McCarty & Marie McCarthy, on the skills & expertise needed to best use mHealth to transform clinical trials.
Converging Goals: How a Focus on the Patient Drives Stronger Healthcare Partnerships
The foundation of healthcare is shifting from a provider- based to a patient-centric, or value-based, model. Read more in this recent MPO Magazine article.
How ICON is Using Analytics & Wearables to Enhance Clinical Trials
The company is investing in emergent technology to boost the attractiveness of trials as a care option and attract more participants.
21st Century Cures Act: Ushering in a New Chapter in the Expanding Use of Real-World Evidence
A recent ICON article published by PharmaFocus on the 21st Century Cures Act and the relative expanding use of real-world evidence (RWE).